Zobrazeno 1 - 10
of 65
pro vyhledávání: '"F. Ezzet"'
Autor:
F. Ezzet, D. Wexler, P. Statkevich, T. Kosoglou, J. Patrick, L. Lipka, L. Mellars, E. Veltri, V. Batra
Publikováno v:
The Journal of Clinical Pharmacology. 41:943-949
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5ee87bb72474614b6405ea2d5e09533
https://doi.org/10.1177/009127000104100903
https://doi.org/10.1177/009127000104100903
Publikováno v:
Biopharmaceutics & Drug Disposition. 19:237-244
Twelve young (mean age 23 years, range 18–28) and 12 elderly (mean age 76 years, range 65–89) volunteers were given a single oral dose of 80 mg valsartan after an overnight fast. Each group consisted of six male and six female subjects. Mean syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3bc94531b79926aa9fdba9294ceb26e
https://doi.org/10.1002/(sici)1099-081x(199805)19:4<237::aid-bdd100>3.0.co
https://doi.org/10.1002/(sici)1099-081x(199805)19:4<237::aid-bdd100>3.0.co
Autor:
F. Ezzet, P. Trunet, J. Godbillon, H. Howald, Antoine Sioufi, N. Sandrenan, C. Czendlik, Ch. Pfister
Publikováno v:
Biopharmaceutics & Drug Disposition. 18:489-497
Letrozole is a new non-steroidal inhibitor of the aromatase enzyme system. It is currently under development for the treatment of postmenopausal women with advanced breast cancer. To investigate the influence of food on the bioavailability of letrozo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0f649ec1a30b47eef2b731efb97b6a9
https://doi.org/10.1002/(sici)1099-081x(199708)18:6<489::aid-bdd36>3.0.co
https://doi.org/10.1002/(sici)1099-081x(199708)18:6<489::aid-bdd36>3.0.co
Autor:
F Zognbi, B Aupetit, F Girard, Ajay S. Bhatnagar, J Menard, Patrick Trunet, F Ezzet, P Mueller
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 74:571-576
The aim of this double blind placebo-controlled cross-over study was to evaluate the effects of fadrozole, a new oral nonsteroidal aromatase inhibitor, on basal and stimulated cortisol and aldosterone secretion at a daily dosage of 4 mg given for 14
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd992e615455cc507a3dfe1861f60fcd
https://doi.org/10.1210/jcem.74.3.1531483
https://doi.org/10.1210/jcem.74.3.1531483
Publikováno v:
Clinical pharmacokinetics. 37(2)
The combination of artemether and lumefantrine (benflumetol) is a new and very well tolerated oral antimalarial drug effective even against multidrug-resistant falciparum malaria. The artemether component is absorbed rapidly and biotransformed to dih
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1888e6e3c905075532abf440c0732229
https://pubmed.ncbi.nlm.nih.gov/10496300
https://pubmed.ncbi.nlm.nih.gov/10496300
Publikováno v:
Biopharmaceuticsdrug disposition. 19(4)
Twelve young (mean age 23 years, range 18-28) and 12 elderly (mean age 76 years, range 65-89) volunteers were given a single oral dose of 80 mg valsartan after an overnight fast. Each group consisted of six male and six female subjects. Mean systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::937f057109ee4cc3de9fd921b4a4db91
https://pubmed.ncbi.nlm.nih.gov/9604123
https://pubmed.ncbi.nlm.nih.gov/9604123
Autor:
A, Sioufi, N, Sandrenan, J, Godbillon, P, Trunet, C, Czendlik, H, Howald, C, Pfister, F, Ezzet
Publikováno v:
Biopharmaceuticsdrug disposition. 18(6)
Letrozole is a new non-steroidal inhibitor of the aromatase enzyme system. It is currently under development for the treatment of postmenopausal women with advanced breast cancer. To investigate the influence of food on the bioavailability of letrozo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8cc8ebf940bf97d6b4c164fc3b1bd959
https://pubmed.ncbi.nlm.nih.gov/9267682
https://pubmed.ncbi.nlm.nih.gov/9267682
Publikováno v:
European journal of clinical pharmacology. 51(3-4)
Objective: Bioavailability of estradiol delivered from a newly developed matrix-type transdermal therapeutic system (MTTS) was compared with that of the conventional reservoir-type system (RTTS). Both formulations have a nominal delivery rate of 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5102a95e19fbd348e3a8ee8ddc91baa6
https://pubmed.ncbi.nlm.nih.gov/9010707
https://pubmed.ncbi.nlm.nih.gov/9010707
Publikováno v:
Maturitas. 27:90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd3423222c7ec762e49c1fef7e83f98b
https://doi.org/10.1016/s0378-5122(97)81113-9
https://doi.org/10.1016/s0378-5122(97)81113-9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.